In the first OrionNOW we deal with prostate cancer. Your suggestions for future themes are most welcome. Please submit your proposal via the Feedback facility.
The distribution rights for the DDDA animal sedatives product family have been returned to Orion European-wide from Pfizer. Read about the arrangement and the new setting for the supply of the products.
The Bonfemi dietary supplement (packaging size 60 capsules) contains genetically modified flaxseed (FP967) that is not authorised in the EU, and it is therefore being recalled from the market. The product is available by Orion in Finland only.
This corporate website provides information about the Orion Group and its operations. Kindly send a message if you're willing to suggest how to improve our pages. More»
What is well-being? Is it success at work, enjoyable family life or good achievements in sports?
Read more
